$AAPL, $BIIB, $CZR, $COP, $DLPH
Below is a list of Wall Street’s Top analysts outlook for Key issues for Tuesday, as follows:
Apple Inc. (NASDAQ:AAPL) analysts maintained as Market Perform at BMO Capital Markets ahead of earnings, but the firm raised its target price to 184 from 171. Apple has a 52-wk trading range of 147.30 – 194.20 and a consensus target price of 202.08.
Biogen Inc. (NASDAQ:BIIB) was reiterated as Buy and the price target was raised to 396 from 335 at Canaccord Genuity. Biogen had a consensus target price of 367.08.
Caesars Entertainment Corp. (NASDAQ:CZR) was started as Buy and was assigned a 14 price objective at Merrill Lynch, and the consensus target price is 15.83.
ConocoPhillips (NYSE:COP) was reiterated as Outperform and the price target was raised to 85 from 82 at RBC Capital Markets, and the consensus analyst target is $78.23.
Delphi Technologies PLC (NYSE:DLPH) was raised to Outperform from Perform and assigned a 53 price target at Oppenheimer, and consensus target price at 58.31.
Latest posts by Paul Ebeling (see all)
- Commentary: Paul Ebeling on Wall Street - August 26, 2019
- Asia: Gold, USD, Crude Oil, Stocks & Commodities - August 26, 2019
- President Trump to Work with G-7 Allies to Build a Future of Opportunity and Promise for All Our Nations - August 25, 2019